pyrroles has been researched along with Astrocytoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Capone, S; Ketonen, L; Subbiah, V; Weathers, SP | 1 |
| Fujimoto, K; Fukui, H; Horio, S; Kawakami, N; Miyoshi, K; Umehara, H | 1 |
| Lee, YS; Sayeed, MM; Wurster, RD | 1 |
3 other study(ies) available for pyrroles and Astrocytoma
| Article | Year |
|---|---|
Activity of Pemigatinib in Pilocytic Astrocytoma and
Topics: Astrocytoma; Humans; Morpholines; Mutation; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1 | 2022 |
Down-regulation of histamine H1 receptors by beta2-adrenoceptor-mediated inhibition of H1 receptor gene transcription.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Astrocytoma; Carbazoles; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Fenoterol; Humans; Promoter Regions, Genetic; Pyrroles; Receptors, Histamine H1; RNA Stability; RNA, Messenger; Transcription, Genetic | 2008 |
In vitro antitumor activity of cromakalim in human brain tumor cells.
Topics: Antineoplastic Agents; Astrocytoma; Benzopyrans; Brain; Brain Neoplasms; Calcium; Cell Survival; Cromakalim; Dose-Response Relationship, Drug; Humans; Neuroblastoma; Potassium Channels; Pyrroles; Sulfonylurea Compounds; Tumor Cells, Cultured | 1994 |